CBL control bionics limited

This time from Forsyth Barr (kiwi mob) CBL Corporation...

  1. 511 Posts.
    lightbulb Created with Sketch. 201
    This time from Forsyth Barr (kiwi mob)

    CBL Corporation OUTPERFORM
    Strategy Execution - Acquiring PfP
    CBL has successfully acquired Professional Fee Protection (PfP), an
    insurance broker in the UK, as part of its ongoing growth strategy into
    niche insurance markets globally. The acquisition, at attractive multiples, is
    a good strategic fit and provides ongoing organic growth opportunities
    through the addition of new products and channels to market. We estimate
    FY16E EPS accretion from the acquisition of +6%, while favourable
    currency movements also boost our future earnings expectations. CBL is
    trading at an attractive forward PE of 11.5x and we maintain our
    OUTPERFORM rating.
    What’s changed?
    Earnings: FY15/16/17 EPS have moved -0.6%/+8.9%/+11.2%
    Target Price: Increased +39cps to NZ$2.56
    Rating: We reiterate our OUTPERFORM rating
    Acquisition of Professional Fee Protection (PfP)
    CBL has acquired 92% of PfP for NZ$17m (£7.5m), on an estimated forward
    multiple of 6.8x. PfP specialises in tax investigation insurance, providing cover for
    any fees that accountants and SME’s face should the UK’s tax and customs
    authority (the HMRC) undertake an examination of tax accounts. PfP has access
    to over 5,000 customers, and offers up to a maximum £100,000 in cover across
    an array of products. PfP is a Managing General Agency (essentially an
    insurance broker in this case) and as such takes no insurance risk. On this basis
    no material solvency capital requirements exist. The company generates
    revenues through fees and commissions.
    In line with strategic objectives
    PfP’s modus operandi aligns with the CBL model. The company operates in a
    niche insurance market with policies that generate similar underwriting profit
    outcomes as those currently pursued by CBL. Strategically CBL will be able to
    leverage the new products into its current markets, as well as some of its current
    products through the new channel to market. All staff have been retained, with
    current PfP CEO Kevin Igoe and Sales Director James Howell maintaining an 8%
    share of the business, thus aligning incentives.
    Accretive to short term earnings – adds longer term growth proposition
    We estimate EPS accretion in FY16E of +6% from the acquisition of PfP. Longer
    term, the ability to leverage the products elsewhere will provide growth options,
    while CBL’s European-domiciled insurance subsidiary CBLIE is well positioned to
    take on tax investigation insurance risk as the company further analyses the
    claims profile of policies. Our earnings revisions account for the acquisition of
    PfP, as well as the favourable currency movements that will drive NZ dollar
    earnings higher.
    12-month Target Price NZ$2.56
    Expected share price return 13.8%
    Net dividend yield 2.6%
    Total 12-month estimated return 16.4%
    Risk assessment Medium
    Market Data
    NZX code CBL
    Share price NZ$2.25
    Issued shares 219.7m
    Market cap NZ$494.3m
    Average daily turnover 317.4k (NZ$572k)
    Share Price Performance
    $1.50
    $1.70
    $1.90
    $2.10
    $2.30
    $2.50
    Oct15 Nov15 Dec15
    Financials (NZ$m) 14A 15E 16E 17E
    NPAT* 20.5 26.3 44.0 54.0
    EPS* (NZc) 9.4 12.0 20.0 24.6
    EPS growth* (%) 14.4 28.1 67.2 22.7
    DPS (NZc) 6.4 0.0 5.8 7.1
    Imputation (%) 100 100 100 100
    Valuation (x) 14A 15E 16E 17E
    EV/EBITDA n/a n/a n/a n/a
    EV/EBIT n/a n/a n/a n/a
    PE 24.1 18.8 11.2 9.2
    Price / NTA 14.1 3.4 2.8 2.3
    Gross dividend yield (%) 3.9 0.0 3.6 4.4
    *Historic and forecast numbers based on underlying profits
    Financials Sector
    James Bascand
    [email protected]
    +64 4 495 5264
    Investment View
    CBL offers investors leverage to offshore earnings generated by a provider
    of specialty insurance products. The company operates a differentiated
    insurance model maintaining a best-in-market claims ratio through effective
    underwriting, and has demonstrated its ability to materially grow earnings​
    over a number of years. Our rating is OUTPERFORM.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.6¢
Change
-0.004(10.0%)
Mkt cap ! $10.60M
Open High Low Value Volume
3.6¢ 3.6¢ 3.6¢ $7.896K 219.3K

Buyers (Bids)

No. Vol. Price($)
1 30672 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 60000 1
View Market Depth
Last trade - 15.59pm 05/09/2025 (20 minute delay) ?
CBL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.